Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Die Lesesäle für Geisteswissenschaften, Naturwissenschaften, der Alte Lesesaal Technik und der Anne-Frank-Shoah-Lesesaal in Leipzig schließen am 04.02.2026 wegen einer Veranstaltung bereits um 15 Uhr. Die weiteren Lesesäle sowie die Servicetheke sind zu den regulären Zeiten geöffnet. //
The humanities reading room, the natural science reading room, the old technology reading room and the reading room of the Anne-Frank-Shoah-Library will close at 15:00 on 4 February 2026 due to an event. The other reading rooms and the service desk will be open during regular hours.

Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

9201 - 9210 von 9932

	9201	Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial Enthalten in Trials Bd. 21, 10.7.2020, Nr. 1, date:12.2020: 1-2
	9202	Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan Enthalten in Reproductive health Bd. 17, 5.6.2020, Nr. 1, date:12.2020: 1-9
	9203	Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial Enthalten in Trials Bd. 24, 3.1.2023, Nr. 1, date:12.2023: 1-17
	9204	Testosteronbehandlung zur Diabetesprävention? Enthalten in Der Diabetologe Bd. 17, 21.5.2021, Nr. 4, date:6.2021: 452-454
	9205	Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial Enthalten in Supportive care in cancer Bd. 21, 8.5.2013, Nr. 9, date:9.2013: 2599-2607
	9206	Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials Enthalten in BMC medicine Bd. 11, 18.4.2013, Nr. 1, date:12.2013: 1-12
	9207	Thalidomid gegen Chemotherapie-induziertes verzögertes Erbrechen Enthalten in Im Focus Onkologie Bd. 21, 6.3.2018, Nr. 3, date:3.2018: 63
	9208	The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial Enthalten in Arthritis Research & Therapy Bd. 19, 25.1.2017, Nr. 1, date:12.2017: 1-10
	9209	The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design Enthalten in Journal of cachexia, sarcopenia and muscle Bd. 2, 16.10.2011, Nr. 4, date:12.2011: 201-207
	9210	The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706) Enthalten in Cancer communications Bd. 39, 7.11.2019, Nr. 1, date:12.2019: 1-8